Inactivation of the von Hippel–Lindau (VHL) tumour-suppressor gene is linked to the development of several different tumour types in humans, including tumours of the kidney, retina, central ...
WELIREG, Merck's oral hypoxia-inducible factor-2 alpha (HIF-2a) inhibitor, has been recommended as monotherapy for the treatment of adult patients with certain types of Von Hippel-Lindau or VHL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback